The cardiac glycoside digitoxin, which possesses both potent cardiac and anticancer activities, is the combination of two natural products, the aglycon digitoxigenin and the trisaccharide digitoxose.
Recently, was constructed a neoglycoside library of digitoxin analogues with improved anticancer activity yet lower cardiotoxicity.
To delineate the pharmalogical role the tris-2-deoxy sugar plays in the biological activity of digitoxin, synthetic access to digitoxin and its bis- and mono-saccharide analogues are desired.
For your research, we can offer the bis- and monosaccharide analogue of digitoxin:
|CAS-No. 18404-43-8||CAS-No. 16479-50-8|
Contact us for enquiries about these compounds or other compounds necessary to support your needs. We look forward to hearing from you.